City

Bunkyo-Ku (1)

Minato-Ku (1)

New Haven (1)

Okayama (1)

Osaka (1)

Sapporo (1)

Seoul (1)

Suita (1)

Yokohama (1)

Condition

XLH (3)

HHRH (1)

Hypercalciuria (1)

Hypophosphatemia (1)

Muscle Weakness (1)

Rickets (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

early phase 1 (1)

n/a (1)

phase 3 (1)

Sponsor

Assistance Publique - Hopitaux de Paris (1)

Kyowa Kirin Co., Ltd. (1)

Yale University (1)

Collaborator

Intervention

krn23 (1)

mri (1)

phosphate (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

xlh

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

XLH Trial in Japan, Korea, Republic of (KRN23)

Completed

XLH

KRN23

Sapporo, Hokkaido, Japan
+9 more

Sep 1, 2022

Hypophosphatemia, Rickets, Hypercalciuria Trial in New Haven (phosphate)

Recruiting

Hypophosphatemia
+4 more

phosphate

New Haven, Connecticut

Yale University School of Medicine

May 17, 2022

Muscle Weakness, XLH Trial (MRI)

Not yet recruiting

Muscle Weakness
XLH

MRI

(no location specified)

Mar 28, 2022